Prospective Survey of Menstrual Migraine & Prevention With Eletriptan

Completed · Phase 4

Conditions studied: Migraine

In brief

Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.

Key facts

Study ID

NCT00259649

Run by

University of Pittsburgh

People needed

71

Starts

2004-08-01

Last updated by the study team

2011-07-04

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• age 18-45 healthy menstruating female

You may not qualify if…

• cardiac or other conditions precluding use of eletriptan

Where it is running

• University of Pittsburgh — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.